Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful

 

Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful

The FDA’s breakthrough therapy tag is meant to speed the development and review of drugs aimed at life-threatening conditions that may boost the standard of care. This article appears in: World …

More Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful Videos

Leave a Reply